Anavex Life Sciences Corp (AVXL)

[ClosetInvestor]

Seems highly unlikely that they’d conditionally approve 2-73 based on 22 of 32 patients. The trial is small, unblinded and with out a placebo arm.

But if you have 24 weeks of data from 450 patients in a properly conducted trial, conditional approval could be a possibility. Unfortunately, as someone pointed out yesterday, AVXL will not be revealing interim data on the phase 2b/3.